Abstract
Given the Covid-19’ sudden rapid spread in the community since 25 July 2020, an updated analysis of Covid-19 cases was conducted to examine the differences of characteristics of Covid-19 patients before versus after lockdown end in Vietnam. Data of 569 Covid-19 patients who were confirmed SARS-CoV-2 infection from 23 January to 31 July, 2020 was collected from official database of the Ministry of Health of Vietnam and the website of Our World in Data. We divided Covid-19 situation timeline from 23 January to 31 July 2020 into two main periods, before lockdown end (23 January – 22 April, 2020) and after lockdown end (23 April – 31 July, 2020). We found the significant variations in the distribution of Covid-19 patients among different provinces between two periods. Patients had a median age of 38.56 (SD 16.61) years, and the patients in the time after lockdown end were older than those in the period before lockdown end by a median of 5 years. Compared to the phase before lockdown with 268 discharged Covid-19 patients (100%) and no Covid-19 death, post lockdown period had only 34.88% patients cured and discharged from the facilities with 5 fatalities (1.66%) and 191 those being under treatment (63.46%). Significant differences in Covid-19 patients were also observed according to nationality and China travel history before and after lockdown end (p <0.05). Importantly, the number of Covid-19 patients who returned from other countries (excluding China) slightly increased through two stages (p >0.05), partially showing that the continuous volume of people returning Vietnam from abroad during the Covid-19 epidemic. Our analysis indicated demographic and epidemiological disparity of Covid-19 patients before versus after loosening the national lockdown in Vietnam. It is important to suggest that, Vietnam’ proactive efforts in Covid-19 control after lockdown end will be effective when the measures to closely control and monitor repatriation and immigration via its borders are strictly enforced.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was conducted in support of an ongoing public health response. There is no funding for this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data are available on reasonable request.